Lamassu Biotech

Executive Summary

Lamassu Biotech is a private, clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, founded in 2021. The company employs a patient-centric, collaborative model to accelerate the development of novel, targeted small molecule therapeutics for areas of high unmet medical need. By leveraging strong preclinical data and translational expertise, Lamassu aims to efficiently advance its pipeline into and through early clinical trials. While specific program details are not publicly disclosed, the company's focus on precision medicine and efficient drug development positions it to address significant gaps in current treatment paradigms.

Upcoming Catalysts (preview)

• Q4 2026Phase 1 Data Readout for Lead Candidate60% success
• Q3 2026Series A Financing Round55% success
• Q1 2027IND Filing for Second Program50% success